Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Shares Issued (2020 - 2025)

Celularity has reported Shares Issued over the past 6 years, most recently at -$1.4 million for Q3 2025.

  • Quarterly results put Shares Issued at -$1.4 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $1.0 million (down 89.38% YoY), and the annual figure for FY2024 was $6.0 million, down 52.94%.
  • Shares Issued for Q3 2025 was -$1.4 million at Celularity, down from $2.5 million in the prior quarter.
  • Over the last five years, Shares Issued for CELU hit a ceiling of $83.2 million in Q4 2021 and a floor of -$29.1 million in Q4 2022.
  • Median Shares Issued over the past 5 years was $1.4 million (2023), compared with a mean of $8.7 million.
  • Biggest five-year swings in Shares Issued: soared 96617.44% in 2021 and later tumbled 135.03% in 2022.
  • Celularity's Shares Issued stood at $83.2 million in 2021, then tumbled by 135.03% to -$29.1 million in 2022, then skyrocketed by 112.87% to $3.8 million in 2023, then surged by 60.0% to $6.0 million in 2024, then plummeted by 123.75% to -$1.4 million in 2025.
  • The last three reported values for Shares Issued were -$1.4 million (Q3 2025), $2.5 million (Q1 2025), and $6.0 million (Q1 2024) per Business Quant data.